Association of systemic inflammation with major adverse cardiovascular events in patients with acute myocardial infarction.

Chi Nguyen¹, Amanda M Ackermann¹, Erica Marieb¹, Jeffrey R Skaar¹, Wing Chow¹, Radha Ryali¹, Lyuba Popadic², Xiyuan Wu², Xinshuo Ma², Kathleen E Kearney³

¹Novo Nordisk Inc, Plainsboro, NJ, USA.

²Komodo Health, New York, NY, USA.

³University of Washington School of Medicine, Seattle, WA, USA.

PubMed PMC DOI PDF

Abstract

OBJECTIVE: Assess the association of systemic inflammation (SI) with major adverse cardiovascular events (MACE) and heart failure (HF) in patients with acute myocardial infarction (AMI). METHODS: This retrospective cohort study included adults hospitalized for type 1 AMI from July 2016 through December 2023 in the Komodo Healthcare Map database. High-sensitivity C-reactive protein (hsCRP) test re…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.